|
1
|
Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon.
|
J Cardiovasc Electrophysiol
|
2011
|
2.67
|
|
2
|
Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multicenter study.
|
Heart Rhythm
|
2012
|
1.08
|
|
3
|
Immunologic treatments for precancerous lesions and uterine cervical cancer.
|
J Exp Clin Cancer Res
|
2014
|
0.96
|
|
4
|
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.
|
Breast Cancer Res Treat
|
2013
|
0.94
|
|
5
|
The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: a comprehensive meta-analysis.
|
Am Heart J
|
2013
|
0.91
|
|
6
|
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study.
|
Breast Cancer Res Treat
|
2014
|
0.88
|
|
7
|
Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study.
|
J Interv Card Electrophysiol
|
2014
|
0.88
|
|
8
|
Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials.
|
PLoS One
|
2013
|
0.87
|
|
9
|
A phase II trial of docetaxel and vinorelbine in patients with advanced breast cancer previously treated with anthracyclines.
|
Oncology
|
2008
|
0.85
|
|
10
|
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.
|
Breast Cancer Res Treat
|
2014
|
0.85
|
|
11
|
Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations.
|
Breast Cancer Res Treat
|
2014
|
0.84
|
|
12
|
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study.
|
J Exp Clin Cancer Res
|
2011
|
0.83
|
|
13
|
Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma.
|
J Exp Clin Cancer Res
|
2009
|
0.83
|
|
14
|
Anthropometric, metabolic and molecular determinants of human epidermal growth factor receptor 2 expression in luminal B breast cancer.
|
J Cell Physiol
|
2015
|
0.81
|
|
15
|
Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer.
|
Gastric Cancer
|
2013
|
0.81
|
|
16
|
Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes.
|
Heart
|
2011
|
0.80
|
|
17
|
Hemodynamic patterns of residual interatrial communication after transcatheter MitraClip repair.
|
J Cardiovasc Med (Hagerstown)
|
2014
|
0.79
|
|
18
|
FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort.
|
J Exp Clin Cancer Res
|
2013
|
0.79
|
|
19
|
Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.
|
J Exp Clin Cancer Res
|
2013
|
0.78
|
|
20
|
Long-term exposure to a high-fat diet results in the development of glucose intolerance and insulin resistance in interleukin-1 receptor I-deficient mice.
|
Am J Physiol Endocrinol Metab
|
2013
|
0.78
|
|
21
|
[Iatrogenic risk of permanent pacemaker and defibrillator implantation].
|
G Ital Cardiol (Rome)
|
2009
|
0.78
|
|
22
|
Large coronary aneurysm following laser angioplasty of the left anterior descending coronary artery.
|
J Cardiovasc Med (Hagerstown)
|
2012
|
0.78
|
|
23
|
Lack of intra-aortic balloon pump effectiveness in high-risk percutaneous coronary interventions without cardiogenic shock: a comprehensive meta-analysis of randomised trials and observational studies.
|
Int J Cardiol
|
2013
|
0.77
|
|
24
|
Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines.
|
Cancer Chemother Pharmacol
|
2010
|
0.77
|
|
25
|
First clinical experience with the new four-pole standard connector for high-voltage ICD leads. Early results of a multicenter comparison with conventional implant outcomes.
|
J Interv Card Electrophysiol
|
2013
|
0.77
|
|
26
|
A novel methodology for AV and VV delay optimization in CRT: results from a randomized pilot clinical trial.
|
J Artif Organs
|
2013
|
0.76
|
|
27
|
Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
|
J Cardiovasc Med (Hagerstown)
|
2011
|
0.76
|
|
28
|
Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.
|
Am J Cardiovasc Drugs
|
2013
|
0.76
|
|
29
|
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.
|
Anticancer Res
|
2009
|
0.76
|
|
30
|
Unusual long-lasting cutaneous complete response to lapatinib and capecitabine in a heavily pretreated HER2-positive plurimetastatic breast cancer patient.
|
Tumori
|
2013
|
0.76
|
|
31
|
Trial sequential analysis: the role of the number needed-to-treat in evaluating the clinical relevance of relative risk reduction values in the intra-aortic balloon pump support.
|
Int J Cardiol
|
2013
|
0.75
|
|
32
|
Arrhythmogenic right-ventricular cardiomyopathy and cardiac microvascular disease: a rare association or a possible link?
|
J Cardiovasc Med (Hagerstown)
|
2017
|
0.75
|
|
33
|
Laparoscopic Debulking Surgery in the Management of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy.
|
Int J Gynecol Cancer
|
2015
|
0.75
|
|
34
|
A rare case of multiple thrombi in a giant left atrium.
|
J Cardiovasc Med (Hagerstown)
|
2017
|
0.75
|
|
35
|
Percutaneous closure of patent foramen ovale with Atriasept II device in nickel allergic patients.
|
J Cardiovasc Med (Hagerstown)
|
2014
|
0.75
|
|
36
|
Transcatheter closure of paravalvular leak secondary to left ventricular peri-annular pseudoaneurysm.
|
Eur Heart J Cardiovasc Imaging
|
2013
|
0.75
|
|
37
|
Transcatheter aortic valve implantation through distal axillary artery: novel option for vascular access.
|
J Cardiovasc Med (Hagerstown)
|
2015
|
0.75
|
|
38
|
Early detection of high voltage lead failure with an unusual and unexpected device alert.
|
Heart
|
2013
|
0.75
|
|
39
|
Endothelial dysfunction is a marker of systemic response to the cardiac resynchronization therapy in heart failure.
|
J Card Fail
|
2013
|
0.75
|
|
40
|
Clinical and electrical performance of currently available MRI-safe pacing systems. Do all devices perform in the same way?
|
Int J Cardiol
|
2012
|
0.75
|
|
41
|
Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system.
|
J Cardiovasc Med (Hagerstown)
|
2013
|
0.75
|
|
42
|
Percutaneous aortic leak closure in a small and frail annulus after double heart valve replacement.
|
J Cardiovasc Med (Hagerstown)
|
2017
|
0.75
|
|
43
|
Surgical and Oncological Outcome of Robotic Surgery Compared With Laparoscopic and Abdominal Surgery in the Management of Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy.
|
Int J Gynecol Cancer
|
2016
|
0.75
|
|
44
|
Hot flushes in women with breast cancer: state of the art and future perspectives.
|
Expert Rev Anticancer Ther
|
2013
|
0.75
|